Company: PAII-WT
Filing Date: 2025-07-21
Form Type: 8-K
Source: 0001213900-25-066199
Chunk: 1

Company: Pyrophyte Acquisition Corp. II
Filing Date: 2025-07-21
Form: 8-K
Item: Item 3.02
Chunk 1
---
Item 3.02. Unregistered Sales of Equity Securities.

On July 18, 2025, simultaneously
with the closing of the IPO, pursuant to the Private Placement Warrants Purchase Agreement, the Company completed the private sale of
an aggregate of 5,050,000 warrants (the “ Private Placement Warrants”) to the Sponsor at a purchase price of $1.00 per
Private Placement Warrant, generating gross proceeds to the Company of $5,050,000. The Private Placement Warrants are identical to the
Warrants included as part of the Units sold in the IPO, except that, for so long as the Private Placement Warrants are held by the Sponsor
or their permitted transferees, the Private Placement Warrants may not (including the Class A Ordinary Shares issuable upon exercise of
the Private Placement Warrants), subject to certain limited exceptions, be transferred, assigned or sold until 30 days after the completion
of the Company’s initial business combination and (ii) are entitled to registration rights. The Private Placement Warrants will
be worthless if the Company does not complete an initial business combination. The material terms of the Private Placement Warrants are
fully described in the Prospectus and are incorporated herein by reference. No underwriting discounts or commissions were paid with respect
to the sale of the Private Placement Warrants. The issuance of the Private Placement Warrants was made pursuant to the exemption from
registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.

Item 5.02. Departure of Directors or Certain
Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On July 16, 2025, in connection
with the IPO, Matteo Pasquali, Per Hornung Pedersen and Jamie Saxton were appointed to the board of directors of the Company. Messrs.
Pasquali, Pedersen and Saxton are independent directors. Effective July 18, 2025, Messrs. Pasquali, Pedersen and Saxton were appointed
to the Board’s Audit Committee, with Mr. Pedersen serving as the chair of the Audit Committee. Effective July 18, 2025, Messrs.
Saxton and Pasquali were appointed to the Board’s Compensation Committee and the Nominating and Corporate Governance Committee,
with Mr. Pasquali serving as chair of the Compensation Committee and Mr. Pasquali serving as chair of the